CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Carfilzomib

卡非佐米 杂质对照品Carfilzomib Impurities

59 个杂质条目59 impurity entries

本页汇总 卡非佐米 的 59 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 59 impurity reference standards of Carfilzomib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 卡非佐米(Carfilzomib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a sustainable UHPLC method for quantification and impurity profiling of carfilzomib
    Scientific reports · 2025 · Patel H et al.  ·  PMID 41444775  ·  DOI
  2. 杂质研究Impurity studiesA UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor
    Journal of pharmaceutical and biomedical analysis · 2016 · Sestak V et al.  ·  PMID 26994320  ·  DOI
  3. 分析方法Analytical MethodsQuantitative determination of carfilzomib in mouse plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study
    Journal of pharmaceutical and biomedical analysis · 2017 · Min JS et al.  ·  PMID 28918323  ·  DOI
  4. 分析方法Analytical MethodsGreen RP-HPLC method for the estimation of carfilzomib in bulk, protein nanocarriers and human plasma: Application of chemometrics and Monte-Carlo simulations
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2024 · Panjwani D et al.  ·  PMID 39561466  ·  DOI
  5. 分析方法Analytical MethodsPhysicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2017 · Kim SH, Krämer I  ·  PMID 29059027  ·  DOI

卡非佐米 —— 原料药与杂质对照品Carfilzomib — drug substance & impurities

共 60 个条目(含原料药本体)60 items incl. the drug substance
Carfilzomib structure
原料药 APIAPIPeptide
卡非佐米Carfilzomib
Carfilzomib
Short peptide: pyrazine-2-carbonyl-Phe-leucine-epoxyketone (peptidomimetic)
CAS No.868540-17-4
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
MK
卡非佐米杂质MKCarfilzomib Impurity MK
Carfilzomib Impurity MK
CAS No.247068-81-2
Chemical FormulaC10H18O2
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 1 structure
1
卡非佐米杂质1Carfilzomib Impurity 1
Carfilzomib Impurity 1
CAS No.875309-92-5
Chemical FormulaC38H48N4O6
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity N1 structure
N1
卡非佐米杂质N1Carfilzomib Impurity N1
Carfilzomib Impurity N1
CAS No.1890999-52-6
Chemical FormulaC40H58ClN5O7
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 2 structure
2
卡非佐米杂质2Carfilzomib Impurity 2
Carfilzomib Impurity 2
CAS No.1541172-75-1
Chemical FormulaC40H59N5O8
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 3 structure
3
卡非佐米杂质3Carfilzomib Impurity 3
Carfilzomib Impurity 3
CAS No.1660143-42-9
Chemical FormulaC40H57N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 5 structure
5
卡非佐米杂质5Carfilzomib Impurity 5
Carfilzomib Impurity 5
CAS No.2049025-45-6
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 6 structure
6
卡非佐米杂质6Carfilzomib Impurity 6
Carfilzomib Impurity 6
CAS No.2419266-62-7
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 8 structure
8
卡非佐米杂质8Carfilzomib Impurity 8
Carfilzomib Impurity 8
CAS No.890660-08-9
Chemical FormulaC27H35N3O5
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 9 structure
9
卡非佐米杂质9Carfilzomib Impurity 9
Carfilzomib Impurity 9
CAS No.2049025-76-3
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 11 structure
11
卡非佐米杂质11Carfilzomib Impurity 11
Carfilzomib Impurity 11
CAS No.868540-15-2
Chemical FormulaC37H47N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 12 structure
12
卡非佐米杂质12Carfilzomib Impurity 12
Carfilzomib Impurity 12
CAS No.2049024-37-3
Chemical FormulaC37H47N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 13 structure
13
卡非佐米杂质13Carfilzomib Impurity 13
Carfilzomib Impurity 13
CAS No.2049024-22-6
Chemical FormulaC37H47N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 14 structure
14
卡非佐米杂质14Carfilzomib Impurity 14
Carfilzomib Impurity 14
CAS No.2049025-59-2
Chemical FormulaC40H57N5O7
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 14 structure
14
卡非佐米杂质14Carfilzomib Impurity 14
Carfilzomib Impurity 14
CAS No.7280-77-5
Chemical FormulaC15H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 16 structure
16
卡非佐米杂质16Carfilzomib Impurity 16
Carfilzomib Impurity 16
CAS No.247068-82-2
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 17 structure
17
卡非佐米杂质17Carfilzomib Impurity 17
Carfilzomib Impurity 17
CAS No.247068-81-1
Chemical FormulaC14H25NO3
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 18 structure
18
卡非佐米杂质18Carfilzomib Impurity 18
Carfilzomib Impurity 18
CAS No.247068-83-3
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 19 structure
19
卡非佐米杂质19Carfilzomib Impurity 19
Carfilzomib Impurity 19
CAS No.2381627-87-6
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 20 structure
20
卡非佐米杂质20Carfilzomib Impurity 20
Carfilzomib Impurity 20
CAS No.2177287-68-0
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 21 structure
21
卡非佐米杂质21Carfilzomib Impurity 21
Carfilzomib Impurity 21
CAS No.13139-15-6
Chemical FormulaC11H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 22 structure
22
卡非佐米杂质22Carfilzomib Impurity 22
Carfilzomib Impurity 22
CAS No.3235-69-6
Chemical FormulaC6H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 25 Monomer structure
25
卡非佐米杂质25单体Carfilzomib Impurity 25 Monomer
Carfilzomib Impurity 25 Monomer
CAS No.1541171-67-8
Chemical FormulaC40H58ClN5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 26 structure
26
卡非佐米杂质26Carfilzomib Impurity 26
Carfilzomib Impurity 26
CAS No.38155-18-9
Chemical FormulaC16H24N2O3
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 30 structure
30
卡非佐米杂质30Carfilzomib Impurity 30
Carfilzomib Impurity 30
CAS No.868540-16-3
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 34 structure
34
卡非佐米杂质34Carfilzomib Impurity 34
Carfilzomib Impurity 34
CAS No.2049024-77-1
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 35 structure
35
卡非佐米杂质35Carfilzomib Impurity 35
Carfilzomib Impurity 35
CAS No.2049024-62-4
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 37 structure
37
卡非佐米杂质37Carfilzomib Impurity 37
Carfilzomib Impurity 37
CAS No.254888-42-1
Chemical FormulaC36H50N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 39 structure
39
卡非佐米杂质39Carfilzomib Impurity 39
Carfilzomib Impurity 39
CAS No.875309-82-3
Chemical FormulaC40H57N5O7
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 40 structure
40
卡非佐米杂质40Carfilzomib Impurity 40
Carfilzomib Impurity 40
CAS No.1672698-88-2
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 41 structure
41
卡非佐米杂质41Carfilzomib Impurity 41
Carfilzomib Impurity 41
CAS No.2049025-67-2
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 42 structure
42
卡非佐米杂质42Carfilzomib Impurity 42
Carfilzomib Impurity 42
CAS No.2049025-49-0
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 43 structure
43
卡非佐米杂质43Carfilzomib Impurity 43
Carfilzomib Impurity 43
CAS No.1140908-89-9
Chemical FormulaC32H44N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 44 structure
44
卡非佐米杂质44Carfilzomib Impurity 44
Carfilzomib Impurity 44
CAS No.247068-85-5
Chemical FormulaC9H17NO2·C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 45 structure
45
卡非佐米杂质45Carfilzomib Impurity 45
Carfilzomib Impurity 45
CAS No.70637-26-2
Chemical FormulaC27H36N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 47 structure
47
卡非佐米杂质47Carfilzomib Impurity 47
Carfilzomib Impurity 47
CAS No.72080-89-8
Chemical FormulaC13H26N2O3
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 49 structure
49
卡非佐米杂质49Carfilzomib Impurity 49
Carfilzomib Impurity 49
CAS No.1796585-29-9
Chemical FormulaC9H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 55 structure
55
卡非佐米杂质55Carfilzomib Impurity 55
Carfilzomib Impurity 55
CAS No.2049025-83-2
Chemical FormulaC40H59N5O8
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 56 structure
56
卡非佐米杂质56Carfilzomib Impurity 56
Carfilzomib Impurity 56
CAS No.868539-99-5
Chemical FormulaC26H35N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 64 structure
64
卡非佐米杂质64Carfilzomib Impurity 64
Carfilzomib Impurity 64
CAS No.1809093-03-5
Chemical FormulaC9H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 65 structure
65
卡非佐米杂质65Carfilzomib Impurity 65
Carfilzomib Impurity 65
CAS No.1541172-78-4
Chemical FormulaC14H27NO5
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 67 structure
67
卡非佐米杂质67Carfilzomib Impurity 67
Carfilzomib Impurity 67
CAS No.70637-27-3
Chemical FormulaC22H28N2O3
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 69 structure
69
卡非佐米杂质69Carfilzomib Impurity 69
Carfilzomib Impurity 69
CAS No.1541171-68-9
Chemical FormulaC46H62N8O8
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 70 structure
70
卡非佐米杂质70Carfilzomib Impurity 70
Carfilzomib Impurity 70
CAS No.1672699-03-4
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 71 structure
71
卡非佐米杂质71Carfilzomib Impurity 71
Carfilzomib Impurity 71
CAS No.868539-98-4
Chemical FormulaC26H35N3O4
Purity>95%现货In stock
10mg25mg50mg100mg
Carfilzomib Impurity 72 structure
72
卡非佐米杂质72Carfilzomib Impurity 72
Carfilzomib Impurity 72
CAS No.1528769-14-3
Chemical FormulaC9H17NO2·C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 73 structure
73
卡非佐米杂质73Carfilzomib Impurity 73
Carfilzomib Impurity 73
CAS No.1469982-99-7
Chemical FormulaC9H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 74 structure
74
卡非佐米杂质74Carfilzomib Impurity 74
Carfilzomib Impurity 74
CAS No.2443766-79-6
Chemical FormulaC9H17NO2·C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 81 structure
81
卡非佐米杂质81Carfilzomib Impurity 81
Carfilzomib Impurity 81
CAS No.100564-78-1
Chemical FormulaC15H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 82 structure
82
卡非佐米杂质82Carfilzomib Impurity 82
Carfilzomib Impurity 82
CAS No.2419266-61-6
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 83 structure
83
卡非佐米杂质83Carfilzomib Impurity 83
Carfilzomib Impurity 83
CAS No.2419266-66-1
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 85 structure
85
卡非佐米杂质85Carfilzomib Impurity 85
Carfilzomib Impurity 85
CAS No.2049024-67-9
Chemical FormulaC31H42N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 91 structure
91
卡非佐米杂质91Carfilzomib Impurity 91
Carfilzomib Impurity 91
CAS No.1796585-41-5
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 92 structure
92
卡非佐米杂质92Carfilzomib Impurity 92
Carfilzomib Impurity 92
CAS No.2803377-12-8
Chemical FormulaC40H57N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 95 structure
95
卡非佐米杂质95Carfilzomib Impurity 95
Carfilzomib Impurity 95
CAS No.2049024-27-1
Chemical FormulaC37H47N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 97 structure
97
卡非佐米杂质97Carfilzomib Impurity 97
Carfilzomib Impurity 97
CAS No.1890999-53-7
Chemical FormulaC39H55N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 101 structure
101
卡非佐米杂质101Carfilzomib Impurity 101
Carfilzomib Impurity 101
CAS No.3063-05-6
Chemical FormulaC15H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 102 Monomer structure
102
卡非佐米杂质102 单体Carfilzomib Impurity 102 Monomer
Carfilzomib Impurity 102 Monomer
CAS No.1545468-80-1
Chemical FormulaC25H33N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 103 structure
103
卡非佐米杂质103Carfilzomib Impurity 103
Carfilzomib Impurity 103
CAS No.1545469-01-9
Chemical FormulaC30H41N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Carfilzomib Impurity 110 structure
110
卡非佐米杂质110Carfilzomib Impurity 110
Carfilzomib Impurity 110
CAS No.16937-99-8
Chemical FormulaC11H21NO4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

卡非佐米 —— 研究文献与合成路线Carfilzomib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 卡非佐米 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Carfilzomib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation
    Barla I, Efentakis P, Lamprou S, et al. · International journal of molecular sciences · 2023 · 被引 4cited 4
  2. Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
    Tundo GR, Sbardella D, Oddone F, et al. · Biomolecules · 2022 · 被引 3cited 3
  3. Development and validation of a sustainable UHPLC method for quantification and impurity profiling of carfilzomib
    Patel H, Patel G, Chauhan P · Scientific reports · 2025

合成路线文献Synthetic-route papers

  1. Sertraline and Carfilzomib Synergize to Target T-cell Malignancies with Serine/Glycine synthesis activity via Cholesterol Dysregulation, Cellular Stress and Immune Modulation
    Verstraete P, Heylen E, Sánchez-Castillo A, et al. · 2026

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

卡非佐米 杂质谱研究要点Carfilzomib — impurity profiling notes

下面这些是拿到 卡非佐米 的 60 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 60 impurity entries for Carfilzomib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances